鎮静催眠剤の世界市場レポート 2024年

鎮静催眠剤の市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.8％で50億米ドルに成長します。予測期間を展望すると、ヘルスケアインフラの拡大、可処分所得の増加、生活習慣病の急増、天然・ハーブ系睡眠補助薬への消費者の関心の高まり、遠隔医療サービスの拡大などにより成長が見込まれます。予測期間中に予想される主な動向としては、非ベンゾジアゼピン系鎮静催眠剤の選好、ドラッグデリバリー技術の進歩、個別化医療への注目の高まり、デジタルヘルスツールの統合、新しいベンゾジアゼピンの出現などが挙げられます。

ストレスレベルの急増は、当面の鎮静催眠剤市場の拡大を牽引すると予想されます。ストレスレベルとは、困難な状況や避けられない状況によって個人が経験する精神的または感情的な疲労のことです。ストレスレベルが高まる要因としては、仕事と私生活の両立への葛藤、不適切な対処法、従業員の仕事に対するプレッシャーの増大などが挙げられます。鎮静催眠剤は、主に中枢神経系に対する精神安定作用を通じて、平静状態を誘導し、不安レベルを低下させ、個人の緊張を和らげることを目的とした薬理学的薬剤として作用します。例えば、米国精神医学会が2022年12月に実施した調査によると、米国成人の26％以上が2023年初めにストレスレベルの上昇を予想しており、これは前年の20％から増加しています。したがって、ストレスレベルの上昇が鎮静催眠剤市場の成長を促進しています。

鎮静催眠剤市場の主要企業は、競争上の優位性を獲得するために、急性期の興奮治療用舌下フィルムなどの革新的な製品を投入し、製品ポートフォリオの拡充に注力しています。急性期興奮治療用の舌下フィルムは、薬剤を含む薄い溶解可能なフィルムで、舌下に貼付することで血流に速やかに吸収されます。例えば、2022年4月、米国のバイオ医薬品会社であるBioXcel Therapeutics Inc.は、成人の統合失調症または双極性Ⅰ型・Ⅱ型障害に伴う焦燥感の急性管理用に設計された舌下フィルムIGALMIを発表しました。IGALMIは、統合失調症や双極性Ⅰ型・Ⅱ型障害に伴う焦燥感の急性期治療薬として、約10年ぶりの新しい治療薬であり、迅速な作用発現と自己投与が可能なフィルム剤という画期的な特徴を有しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の鎮静催眠剤市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の鎮静催眠剤市場の実績：規模と成長, 2018-2023
• 世界の鎮静催眠剤市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界の鎮静催眠剤市場：薬剤クラス別、実績と予測, 2018-2023, 2023-2028F, 2033F
• ベンゾジアゼピン
• バルビツール酸
• 抗ヒスタミン薬
• 非ベンゾジアゼピン
• その他の薬剤クラス
• 世界の鎮静催眠剤市場：投与経路別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 経口
• 非経口
• その他の投与経路
• 世界の鎮静催眠剤市場：疾患タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 睡眠障害
• 知覚脱失
• 疼痛
• その他の疾患タイプ
• 世界の鎮静催眠剤市場：流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の鎮静催眠剤市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院
• 専門クリニック
• 在宅ケア
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界の鎮静催眠剤市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界の鎮静催眠剤市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鎮静催眠剤市場：競合情勢
• 鎮静催眠剤市場：企業プロファイル
  • Sun Pharmaceutical Industries Inc.
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck And Co. Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi-Aventis AG
• AstraZeneca Plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Fresenius Kabi AG
• Eli Lilly and Co.
• Aurobindo Pharma Limited
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

A sedative-hypnotic drug is a chemical substance employed to alleviate tension, anxiety, and induce a sense of calm (sedative effect), or to facilitate sleep (hypnotic effect). These drugs act by suppressing the limbic system, responsible for emotional and behavioral responses, as well as the reticular formation, which regulates sleep patterns and consciousness.

Key types of sedative-hypnotic drugs include benzodiazepines, barbiturates, antihistamines, nonbenzodiazepines, and others. Benzodiazepines, for instance, decrease activity in the brain and nervous system, offering tranquilizing effects used to alleviate symptoms of anxiety and insomnia. These medications can be administered through various routes, such as oral and parenteral, to treat various conditions including sleep disorders, anesthesia, and pain management. They are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies, serving diverse end-users including hospitals, specialty clinics, and home care settings.

The sedative-hypnotic drugs market research report is one of a series of new reports from The Business Research Company that provides sedative-hypnotic drugs market statistics, including sedative-hypnotic drugs industry global market size, regional shares, competitors with a sedative-hypnotic drugs market share, detailed sedative-hypnotic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the sedative-hypnotic drugs industry. This sedative-hypnotic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historical period can be attributed to several factors, including the expansion of direct-to-consumer advertising, heightened stress levels, increased prevalence of sleep disorders, and aging populations.

The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.00 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. Looking ahead to the forecast period, growth is anticipated due to the expansion of healthcare infrastructure, rising disposable incomes, a surge in lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and the expansion of telemedicine services. Key trends expected in the forecast period include a preference for non-benzodiazepine sedative-hypnotic drugs, advancements in drug delivery technologies, a heightened focus on personalized medicine, integration of digital health tools, and the emergence of new benzodiazepines.

The surge in stress levels is expected to drive the expansion of the sedative-hypnotic drugs market in the foreseeable future. Stress levels denote the mental or emotional exhaustion experienced by individuals due to challenging or unavoidable circumstances. Factors contributing to heightened stress levels include the struggle to balance work and personal life, inadequate coping mechanisms, and escalating work pressure among employees. Sedative-hypnotic drugs act as pharmacological agents primarily aimed at inducing a state of calmness, reducing anxiety levels, and relieving tension within individuals, often through their tranquilizing effects on the central nervous system. For example, as per a survey conducted by the American Psychiatric Association in December 2022, over 26% of American adults anticipated increased stress levels at the beginning of 2023, marking a rise from the 20% reported in the preceding year. Hence, the escalating stress levels are propelling the growth of the sedative-hypnotic drugs market.

Key players in the sedative-hypnotic drugs market are concentrating on broadening their product portfolio by introducing innovative products such as sublingual films for acute treatment of agitation, aiming to gain a competitive advantage. Sublingual films for acute agitation treatment are thin, dissolvable films containing medication placed under the tongue for rapid absorption into the bloodstream. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, unveiled IGALMI, a sublingual film designed for the acute management of agitation associated with schizophrenia or bipolar I or II disorder in adults. IGALMI represents the first new acute treatment for agitation linked to these disorders in nearly a decade, offering healthcare teams an innovative tool with its rapid onset of action and self-administered film format.

In June 2022, Eagle Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Acacia Pharma Group plc for an undisclosed sum. This strategic acquisition enabled Eagle Pharmaceuticals to expand its product portfolio by incorporating two drugs, 'BARHEMSYS' and 'BYFAVO', enhancing its presence in the acute care domain. Both companies aimed to bolster their position in the oncology and hospital sectors by addressing significant unmet clinical needs. Acacia Pharma Group plc, headquartered in the UK, specializes in the manufacturing of sedative-hypnotic drugs.

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

North America was the largest region in the sedative-hypnotic drugs market in 2023. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sedative-hypnotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sedative-hypnotic drugs market consists of sales of tablets, capsules, injectables, and liquid formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sedative-Hypnotic Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sedative-hypnotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sedative-hypnotic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sedative-hypnotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Benzodiazepines; Barbiturates; Antihistamines; Nonbenzodiazepine; Other Drug Classes
• 2) By Route of Administration: Oral; Parenteral; Other Routes of Administration
• 3) By Disease Type: Sleep Disorders; Anesthesia; Pain; Other Disease Types
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Companies Mentioned: Sun Pharmaceutical Industries Inc.; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck And Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sedative-Hypnotic Drugs Market Characteristics

3. Sedative-Hypnotic Drugs Market Trends And Strategies

4. Sedative-Hypnotic Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Sedative-Hypnotic Drugs Market Size and Growth

• 5.1. Global Sedative-Hypnotic Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Sedative-Hypnotic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Sedative-Hypnotic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sedative-Hypnotic Drugs Market Segmentation

• 6.1. Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Benzodiazepines
• Barbiturates
• Antihistamines
• Nonbenzodiazepine
• Other Drug Class
• 6.2. Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Route of Administrations
• 6.3. Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Sleep Disorders
• Anesthesia
• Pain
• Other Disease Types
• 6.4. Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.5. Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users

7. Sedative-Hypnotic Drugs Market Regional And Country Analysis

• 7.1. Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sedative-Hypnotic Drugs Market

• 8.1. Asia-Pacific Sedative-Hypnotic Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sedative-Hypnotic Drugs Market

• 9.1. China Sedative-Hypnotic Drugs Market Overview
• 9.2. China Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sedative-Hypnotic Drugs Market

• 10.1. India Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sedative-Hypnotic Drugs Market

• 11.1. Japan Sedative-Hypnotic Drugs Market Overview
• 11.2. Japan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sedative-Hypnotic Drugs Market

• 12.1. Australia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sedative-Hypnotic Drugs Market

• 13.1. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sedative-Hypnotic Drugs Market

• 14.1. South Korea Sedative-Hypnotic Drugs Market Overview
• 14.2. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sedative-Hypnotic Drugs Market

• 15.1. Western Europe Sedative-Hypnotic Drugs Market Overview
• 15.2. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sedative-Hypnotic Drugs Market

• 16.1. UK Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sedative-Hypnotic Drugs Market

• 17.1. Germany Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sedative-Hypnotic Drugs Market

• 18.1. France Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sedative-Hypnotic Drugs Market

• 19.1. Italy Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sedative-Hypnotic Drugs Market

• 20.1. Spain Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sedative-Hypnotic Drugs Market

• 21.1. Eastern Europe Sedative-Hypnotic Drugs Market Overview
• 21.2. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sedative-Hypnotic Drugs Market

• 22.1. Russia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sedative-Hypnotic Drugs Market

• 23.1. North America Sedative-Hypnotic Drugs Market Overview
• 23.2. North America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sedative-Hypnotic Drugs Market

• 24.1. USA Sedative-Hypnotic Drugs Market Overview
• 24.2. USA Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sedative-Hypnotic Drugs Market

• 25.1. Canada Sedative-Hypnotic Drugs Market Overview
• 25.2. Canada Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sedative-Hypnotic Drugs Market

• 26.1. South America Sedative-Hypnotic Drugs Market Overview
• 26.2. South America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sedative-Hypnotic Drugs Market

• 27.1. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sedative-Hypnotic Drugs Market

• 28.1. Middle East Sedative-Hypnotic Drugs Market Overview
• 28.2. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sedative-Hypnotic Drugs Market

• 29.1. Africa Sedative-Hypnotic Drugs Market Overview
• 29.2. Africa Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sedative-Hypnotic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Sedative-Hypnotic Drugs Market Competitive Landscape
• 30.2. Sedative-Hypnotic Drugs Market Company Profiles
  • 30.2.1. Sun Pharmaceutical Industries Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck And Co. Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Sedative-Hypnotic Drugs Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi-Aventis AG
• 31.3. AstraZeneca Plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan N.V.
• 31.10. Fresenius Kabi AG
• 31.11. Eli Lilly and Co.
• 31.12. Aurobindo Pharma Limited
• 31.13. Cipla Inc.
• 31.14. Dr. Reddy's Laboratories Ltd.
• 31.15. Hikma Pharmaceuticals plc

32. Global Sedative-Hypnotic Drugs Market Competitive Benchmarking

33. Global Sedative-Hypnotic Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market

35. Sedative-Hypnotic Drugs Market Future Outlook and Potential Analysis

• 35.1 Sedative-Hypnotic Drugs Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Sedative-Hypnotic Drugs Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Sedative-Hypnotic Drugs Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer